{
  "meta": {
    "title": "Miscellaneous_Pulmonolog",
    "url": "https://brainandscalpel.vercel.app/miscellaneous-pulmonolog-49b2075f.html",
    "scrapedAt": "2025-11-30T11:13:11.486Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeat dose of corticosteroids</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Mechanical ventilation</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">12 litres oxygen</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Montelukast</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old man with known chronic obstructive pulmonary disease (COPD) is admitted with symptoms of worsening breathlessness and confusion. Following a dose of 200mg IV hydrocortisone and two doses of salbutamol and ipratropium nebulisers, arterial blood gases were taken. His arterial blood gases are as follows: pH 7.18, pO2 49.5 mmHg, pCO2 90 mmHg. What should be done next?</span></p>",
      "unique_key": "DT1196001",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196001,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Severe <strong>acute on chronic</strong> <strong>type II respiratory failure</strong> with acidosis and confusion in COPD requires mechanical ventilation.</p>\r\n<ul>\r\n<li>The ABG shows very high pCO<sub>2</sub> (90 mmHg) with low pH (7.18) &rarr; <strong>Severe acute hypercapnic respiratory failure</strong>.</li>\r\n  <li>In COPD, patients often tolerate chronically raised CO<sub>2</sub> with metabolic compensation, but sudden worsening with confusion and pH &lt;7.25 indicates acute decompensation.</li>\r\n<li>Initial bronchodilators and steroids have already been given, yet the patient is deteriorating.</li>\r\n<li>At this stage, non-invasive ventilation (NIV, e.g., BiPAP) is first-line. If contraindicated or if NIV fails, intubation and invasive mechanical ventilation is needed.</li>\r\n</ul>\r\n<p><strong>Explanation of incorrect options</strong></p>\r\n<p><strong>Repeat dose of corticosteroids (Option A):</strong> Steroids are already given and do not address acute CO<sub>2</sub> retention or hypoxia.</p>\r\n<p><strong>12 litres of oxygen (Option C):</strong> High-flow uncontrolled oxygen can worsen CO<sub>2</sub> retention in COPD by abolishing hypoxic drive. Oxygen should be carefully titrated (e.g., Venturi mask 24-28%).</p>\r\n<p><strong>Montelukast (Option D):</strong> Used in asthma/allergic rhinitis, not in acute COPD exacerbation.</p>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">COPD</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchial obstruction from a tumour</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Kyphoscoliosis</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Obstructive sleep apnoea</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old woman has been breathless and is undergoing investigations for the cause. She has a previous history of being a smoker and has a dry cough as well. Her ABGs show a pO2 of 67 mmHg and pCO2 of 37 mmHg. Lung function tests show reduced vital capacity, reduced TLCO, but increased KCO. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1196004",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196004,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Restrictive lung disease due to chest wall deformity (<strong>kyphoscoliosis</strong>) shows reduced lung volumes and TLCO, but a relatively increased KCO.</p>\n<ul>\n<li><strong>Kyphoscoliosis</strong> is a restrictive lung disease caused by chest wall deformity, leading to reduced vital capacity and reduced total lung capacity.</li>\n<li>The <strong>TLCO</strong> (transfer factor for CO) is low because overall alveolar volume is reduced.</li>\n<li>However, <strong>KCO</strong> (transfer coefficient = TLCO/VA) is increased, since the reduced alveolar volume concentrates gas exchange into a smaller lung unit, making diffusion per unit volume more efficient.</li>\n<li>ABG shows mild hypoxemia (pO<sub>2</sub> 67 mmHg) with normal pCO<sub>2</sub>, consistent with restrictive pathology rather than obstructive disease.</li>\n<li>This pattern (&darr; TLC, &darr; TLCO, &uarr; KCO) is typical of extrapulmonary restrictive disease (e.g., kyphoscoliosis, neuromuscular weakness).</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>COPD (Option A):</strong> Obstructive pattern with &darr;FEV1/FVC, &darr;KCO due to emphysema; not consistent here.</p>\n<p><strong>Bronchial obstruction from a tumour (Option B):</strong> Would cause localized collapse or obstructive pattern, not global restrictive defect with &uarr;KCO.</p>\n<p><strong>Obstructive sleep apnoea (Option D): ABG</strong> usually shows normal values during the day; lung function tests are often normal, not restrictive with &uarr;KCO.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250912f2db5.png\">",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung carcinoma</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchiectasis</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Asthma Asbestosis</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic obstructive pulmonary disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man gives a six-month history of worsening breathlessness and coughs up half a cupful of sputum daily. He was occasionally wheezy with viral illnesses as a young child, works in a factory and has smoked 25 cigarettes per day for the last four years. The most likely diagnosis is:</span></p>",
      "unique_key": "DT1196007",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196007,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Daily production of large volumes of purulent sputum with chronic cough strongly suggests <strong>bronchiectasis</strong>.</p>\n<ul>\n<li><strong>Bronchiectasis</strong> is characterized by chronic cough with large-volume, purulent sputum production, often &gt;10 mL/day, sometimes up to half a cup.</li>\n<li>Patients often describe chronic breathlessness and recurrent chest infections.</li>\n<li>Cigarette smoking is a <strong>risk factor</strong> for COPD but does not typically explain daily large sputum volume at this young age.</li>\n<li>Childhood respiratory illnesses (e.g., recurrent infections, viral bronchiolitis, or whooping cough) can predispose to bronchiectasis by causing airway damage.</li>\n<li>The long history and characteristic sputum volume make bronchiectasis the best diagnosis here.</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Lung carcinoma (Option A):</strong> Can cause cough, haemoptysis, or localized wheeze but not chronic, copious sputum production.</p>\n<p><strong>Asthma/Asbestosis (Option C):</strong> Asthma causes wheeze and dyspnoea with reversible obstruction, but not large sputum volume. Asbestosis is restrictive and associated with occupational exposure, not purulent sputum.</p>\n<p><strong>Chronic obstructive pulmonary disease (Option D):</strong> COPD presents with chronic cough and sputum, but typically develops after many years of smoking (not just 4 years) and sputum is usually less in volume compared to bronchiectasis.</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">House dust mite</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Grass pollen</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Willow pollen</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Isocyanates</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 14-year-old boy develops red eyes and rhinitis frequently at the start of the summer. What is the likely triggering agent?</span></p>",
      "unique_key": "DT1196008",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196008,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Grass pollen</strong> is the most common seasonal allergen responsible for hay fever symptoms in early summer.</p>\n<ul>\n<li>This child presents with allergic <strong>rhinoconjunctivitis</strong> (red eyes + rhinitis), a hallmark of <strong>seasonal allergic rhinitis (hay fever)</strong>.</li>\n<li>The timing is crucial: early summer is when grass pollen (especially rye grass, timothy grass, meadow grasses) peak.</li>\n<li>House dust mite causes perennial (year-round) allergic rhinitis, not seasonal.</li>\n<li>Tree pollens (like willow, birch, alder) typically cause spring allergies, not summer.</li>\n<li>Isocyanates are industrial chemicals that can cause occupational asthma, not seasonal allergic rhinitis in children.</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>House dust mite (Option A):</strong> Perennial allergen, symptoms year-round, worse indoors.</p>\n<p><strong>Willow pollen (Option C):</strong> Peaks in spring, not summer.</p>\n<p><strong>Isocyanates (Option D):</strong> Occupational exposure &rarr; asthma, not rhinitis in teenagers.</p>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Small cell  carcinoma</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell  carcinoma</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma carcinoma</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Large cell carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old man has been confirmed to have lung cancer. Which form of cancer has the worst prognosis?</span></p>",
      "unique_key": "DT1196012",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196012,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Small cell carcinoma of the lung</strong> has the worst prognosis due to its aggressive nature, early metastasis, and poor response to surgery.</p>\n<ul>\n<li>Lung cancers are broadly divided into <strong>non-small cell lung cancer</strong> (NSCLC) and <strong>small cell lung cancer</strong> (SCLC).</li>\n<li>SCLC accounts for &#x7E;15% of lung cancers, is strongly associated with smoking, and originates from neuroendocrine cells.</li>\n<li>It is <strong>characterized</strong> by:\n<ul>\n<li>Rapid growth and early metastasis (especially to the brain, liver, adrenals, and bone).</li>\n<li>Paraneoplastic syndromes (e.g., SIADH, Cushing's syndrome, Lambert-Eaton syndrome).</li>\n<li>Poor prognosis: median survival untreated is only 2-4 months; with therapy, survival is still much worse than NSCLC.</li>\n</ul>\n</li>\n<li>In contrast, NSCLCs (squamous, adeno, large cell) progress more slowly and have comparatively better prognosis.</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Squamous cell carcinoma (Option B):</strong> Usually central, linked to smoking, grows slower than SCLC; better prognosis.</p>\n<p><strong>Adenocarcinoma (Option C):</strong> Most common type, especially in non-smokers and females; relatively better prognosis.</p>\n<p><strong>Large cell carcinoma (Option D):</strong> Poor prognosis but not as aggressive as small cell carcinoma.</p>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Chemotherapy</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiotherapy</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Lobectomy</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumonectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old man presents with a chronic cough. He is a heavy smoker of over 40 cigarettes a day. CXR shows a peripheral right-sided lesion. A biopsy, which was taken, shows squamous cell carcinoma. No regional lymph nodes are involved. Lung function tests show a FEV1 of less than 1.5 litres. The recommended treatment is:</span></p>",
      "unique_key": "DT1196014",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196014,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Radiotherapy</strong> is the treatment of choice in localized lung cancer when surgical resection is contraindicated due to poor lung function (FEV1 &lt; 1.5 L).</p>\n<ul>\n<li>Surgery (lobectomy/pneumonectomy) is the mainstay of treatment in localized non&ndash;small cell lung cancers (like squamous cell carcinoma) if lung function permits.</li>\n<li>However, surgery requires adequate preoperative pulmonary reserve:\n<ul>\n<li>FEV1 &gt; 1.5 L for <strong>lobectomy</strong>.</li>\n<li>FEV1 &gt; 2 L for <strong>pneumonectomy</strong>.</li>\n</ul>\n</li>\n<li>This patient has FEV1 &lt; 1.5 L, making him a poor surgical candidate.</li>\n<li>In such patients, definitive radiotherapy (radical or stereotactic body radiotherapy) is recommended for local control.</li>\n<li><strong>Chemotherapy</strong> is typically used in small cell carcinoma or advanced/metastatic NSCLC, not in isolated early squamous carcinoma without nodal spread.</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Chemotherapy (Option A):</strong> Not first-line for localized squamous carcinoma without metastasis; mainly for advanced disease or palliation.</p>\n<p><strong>Lobectomy (Option C):</strong> Requires FEV1 &gt; 1.5 L; not feasible here.</p>\n<p><strong>Pneumonectomy (Option D):</strong> Requires FEV1 &gt; 2 L; contraindicated in this patient.</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Sulphasalazine</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Penicillamine</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Gold</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man, ex-smoker (20 pack-years), was admitted to the hospital because of a prolonged fever of up to 38.5*deg;C over 10 days, associated with a progressively worsening shortness of breath, a non-productive cough, weakness, and fatigue. The chest radiograph showed consolidations at the base of both lungs, prominent interstitial markings in the middle lung fields, and hazy infiltrates in the right upper lung field. A bronchoscopy was done, and BAL fluid analysis showed alveolitis with macrophages of 65%, lymphocytes of 25%, and neutrophils of 10%. Which drug is most likely to be responsible?</span></p>",
      "unique_key": "DT1196016",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196016,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Methotrexate</strong> commonly causes acute/subacute hypersensitivity pneumonitis/interstitial pneumonitis with fever, dyspnoea, bilateral infiltrates and a BAL lymphocytosis, making it the most likely culprit.</p>\n<ul>\n<li><strong>Presentation &amp; timing</strong>:\n<ul>\n<li>Methotrexate pulmonary toxicity typically presents subacutely with fever, nonproductive cough and progressive dyspnoea; CXR/HRCT often show bilateral patchy consolidation or ground-glass changes.</li>\n<li>Symptoms can occur weeks to months after starting the drug (but timing is variable).</li>\n</ul>\n</li>\n<li><strong>BAL pattern</strong>:\n<ul>\n<li>Drug-induced hypersensitivity pneumonitis/interstitial pneumonitis often shows a lymphocytic alveolitis (elevated lymphocytes on BAL) - the BAL here (lymphocytes 25%) is compatible with a drug-induced interstitial reaction; macrophage predominance is common background but the lymphocyte fraction supports inflammatory interstitial process.</li>\n</ul>\n</li>\n<li><strong>Methotrexate</strong> specifically:\n<ul>\n<li>Well-recognised cause of acute/subacute interstitial pneumonitis independent of dose, sometimes with systemic features (fever, malaise).</li>\n<li>Stopping methotrexate and corticosteroid therapy are typical management steps.</li>\n</ul>\n</li>\n<li><strong>Clinical correlation</strong>:\n<ul>\n<li>Other causes (infective, cardiac, other drugs) must be excluded, but the combination of fever, subacute course, bilateral infiltrates and BAL lymphocytosis strongly points to methotrexate lung.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Sulphasalazine (Option A):</strong> Can rarely cause pulmonary reactions (hypersensitivity pneumonitis) but is a much less common cause than methotrexate and the classic drug associated with this presentation in adults with these BAL findings is methotrexate.</p>\n<p><strong>Penicillamine (Option B):</strong> May cause various adverse effects including hypersensitivity reactions and interstitial lung disease rarely, but it is an uncommon culprit compared with methotrexate.</p>\n<p><strong>Gold (Option C):</strong> Injectable gold therapy has been associated with pulmonary toxicity historically (e.g., pulmonary fibrosis) but this is now rare and the typical acute/subacute febrile pneumonitis picture is most classically linked to methotrexate.</p>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Old tuberculosis</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypogammaglobulinaemia</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic fibrosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old woman has a history of cough with copious phlegm with intermittent haemoptysis. She also gets recurrent chest infections and has a long history of joint pains. She is on non-steroidal anti-inflammatory drugs. Her chest radiograph shows linear radiolucency at both bases. A high-resolution computed tomography scan (HRCT) of the chest confirms bronchiectasis. What is the likely cause?</span></p>",
      "unique_key": "DT1196019",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196019,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Bronchiectasis</strong> is a well-recognised extra-articular manifestation of <strong>rheumatoid arthritis</strong>, often presenting as basal changes with recurrent infections.</p>\n<ul>\n<li><strong>Bronchiectasis</strong> is characterised by abnormal and irreversible dilatation of bronchi, leading to chronic productive cough, sputum, haemoptysis, and recurrent infections.</li>\n<li>While many causes exist (post-infective, immune, structural, congenital), connective tissue diseases, especially rheumatoid arthritis (RA), are strongly associated with basal bronchiectasis.</li>\n<li>In RA, chronic immune-mediated inflammation and recurrent infections contribute to airway wall damage, producing this pattern.</li>\n<li><strong>HRCT</strong> is the <strong>gold standard</strong> for diagnosis, showing dilated bronchi and \"<strong>tram-track\"</strong> or \"<strong>signet-ring\"</strong> signs.</li>\n<li>In this case, the joint pains and NSAID use point strongly toward an autoimmune background, most consistent with RA.</li>\n<li><strong>Other causes</strong> (TB, hypogammaglobulinaemia, cystic fibrosis) are possible but less likely given the age, sex, and strong history of RA.</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Old tuberculosis (Option A):</strong> TB can cause post-infective bronchiectasis, typically with upper-lobe involvement and localized changes, not basal predominance as in this case.</p>\n<p><strong>Hypogammaglobulinaemia (Option B):</strong> Leads to recurrent infections and bronchiectasis but usually presents in childhood or early adulthood, with a history of recurrent sinopulmonary infections, which is not given here.</p>\n<p><strong>Cystic fibrosis (Option D):</strong> Common cause of bronchiectasis in young patients but rare at 40 years of age without prior diagnosis; also typically associated with infertility, malabsorption, or family history.</p>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypogammaglobulinemia</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha 1 antitrypsin deficiency</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Defect in CFTR gene</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">kartagener's syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old man has a history of a long-standing cough with sputum production. He also has recurrent episodes of chest infections and sinusitis. He is married but has been unsuccessful in having children. He also has hearing difficulty. Which one of the following is likely?</span></p>",
      "unique_key": "DT1196047",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196047,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Kartagener's syndrome</strong> (a subtype of primary ciliary dyskinesia) presents with chronic sinusitis, bronchiectasis, male infertility (due to immotile sperm), and can be associated with hearing loss due to chronic otitis media.</p>\n<ul>\n<li><strong>Kartagener's syndrome</strong> is an inherited disorder caused by defective dynein arms of cilia, leading to immotile cilia syndrome.</li>\n<li>The <strong>triad</strong> is:\n<ul>\n<li><strong>Bronchiectasis</strong> &rarr; chronic productive cough, recurrent infections.</li>\n<li><strong>Chronic sinusitis</strong> &rarr; nasal obstruction, recurrent sinus infections.</li>\n<li><strong>Situs inversus</strong> (seen in ~50% cases, but not essential).</li>\n<li>Men are infertile because of immotile spermatozoa, and women may also have subfertility due to impaired ciliary action in fallopian tubes.</li>\n<li>Middle ear infections and conductive hearing loss are also common because of impaired mucociliary clearance in the ear.</li>\n</ul>\n</li>\n<li>In this case, the combination of bronchiectasis + sinusitis + infertility + hearing issues fits Kartagener's syndrome perfectly.</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Hypogammaglobulinemia (Option A):</strong> Causes recurrent infections and bronchiectasis, but usually presents in childhood with recurrent pneumonia, otitis, and sinus infections; infertility is not a feature.</p>\n<p><strong>Alpha-1 antitrypsin deficiency (Option B)</strong>: Causes early-onset panacinar emphysema (lower lobe predominant), not bronchiectasis with infertility or sinusitis.</p>\n<p><strong>Defect in the CFTR gene (Option C):</strong> Cystic fibrosis can cause bronchiectasis, infertility, and sinusitis, but usually presents in childhood/young adulthood with pancreatic insufficiency and malabsorption, which is not described here.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025091264031.png\">\n<p><strong>Dextrocardia</strong></p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung Biopsy</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Arrange CT scan of the lungs</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Start prednisolone</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Arrange an outpatient appointment for follow-up</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old woman is referred to with a history of red, painful legs of 3 weeks duration that have not responded to a course of flucloxacillin given for cellulitis. She is afebrile, does not have any other symptoms, and has never smoked. Examination reveals tender purple/red nodules on her shins. A chest radiograph shows prominent hilar regions. What is the appropriate management?</span></p>",
      "unique_key": "DT1196082",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196082,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This patient likely has <strong>sarcoidosis</strong> presenting with erythema nodosum and bilateral hilar lymphadenopathy, which is often self-limiting and best managed with outpatient follow-up rather than immediate invasive tests or steroids.</p>\n<ul>\n<li><strong>Sarcoidosis</strong> is a multisystem granulomatous disease commonly affecting the lungs, skin, and lymph nodes.</li>\n<li>A classic <strong>presentation</strong> is erythema nodosum with bilateral hilar lymphadenopathy, particularly in young women.</li>\n<li>This constellation is part of <strong>L&ouml;fgren's syndrome</strong> (erythema nodosum, bilateral hilar adenopathy, and arthralgia/fever), which is typically acute and self-limiting.</li>\n<li>In such cases, the disease often resolves spontaneously within months, and immediate steroids are not indicated unless there is significant organ involvement (e.g., eye, cardiac, or CNS).</li>\n<li>Invasive procedures like lung biopsy or CT are unnecessary at this stage when the diagnosis is likely and the prognosis is favorable.</li>\n<li>The best course is outpatient monitoring with follow-up.</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Lung Biopsy (Option A):</strong> Reserved for uncertain diagnoses or atypical presentations. Not needed here since clinical and radiographic features strongly suggest sarcoidosis.</p>\n<p><strong>Arrange CT scan of the lungs (Option B):</strong> More detailed imaging may be required if atypical features are present, but here CXR findings are sufficient for diagnosis.</p>\n<p><strong>Start prednisolone (Option C):</strong> Indicated only if there is severe or progressive organ involvement. Not required in L&ouml;fgren's syndrome, which is usually self-limiting.</p>\n<p>Oral corticosteroids (prednisone, 0.5-1.0 mg/kg/day) are indicated for patients with:</p>\n<ul>\n<li>Disabling constitutional symptoms</li>\n<li>Hypercalcemia</li>\n<li>Iritis, uveitis</li>\n<li>Arthritis</li>\n<li>CNS involvement</li>\n<li>Cardiac involvement</li>\n<li>Granulomatous hepatitis</li>\n<li>Cutaneous lesions other than erythema nodosum</li>\n<li>Progressive pulmonary lesions.</li>\n</ul>\n<p>Long-term therapy is usually required for months to years.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025091506b93.png\">\n<p>Sarcoidosis X-ray</p>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Churg-Strauss syndrome</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary fibrosis</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary hypertension</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Allergic Bronchopulmonary aspergillosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old lady presents with worsening breathlessness. She has a history of Raynaud's phenomenon, heartburn and reflux. On examination, the skin over her fingers is tight and shiny. She has multiple telangiectasia over her face, and nail fold capillary loops are seen. Her investigations show she has Anticentromere antibodies. What respiratory complications may occur?</span></p>",
      "unique_key": "DT1196087",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196087,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Patients with limited <strong>cutaneous systemic sclerosis (CREST syndrome)</strong> and anticentromere antibodies are characteristically prone to <strong>pulmonary arterial hypertension (PAH)</strong> rather than pulmonary fibrosis.</p>\n<ul>\n<li><strong>Systemic sclerosis (scleroderma)</strong> is an autoimmune connective tissue disorder that can cause a variety of systemic complications.</li>\n<li>The limited cutaneous subtype (CREST syndrome: Calcinosis, Raynaud&rsquo;s, Esophageal dysmotility, Sclerodactyly, Telangiectasia) is strongly associated with anticentromere antibodies.</li>\n<li>The major pulmonary complication in this subtype is <strong>pulmonary arterial hypertension</strong> (PAH), which results from vascular intimal proliferation and obliteration of pulmonary arterioles.</li>\n<li>Clinically, this leads to progressive exertional dyspnoea, reduced DLCO on lung function testing, and eventual right heart failure if untreated.</li>\n<li>In contrast, diffuse cutaneous systemic sclerosis is more often associated with <strong>anti-Scl-70 antibodies</strong> (anti-topoisomerase I) and <strong>pulmonary fibrosis</strong>.</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Churg-Strauss syndrome (Option A):</strong> An eosinophilic vasculitis with asthma and eosinophilia; not linked to systemic sclerosis or anticentromere antibodies.</p>\n<p><strong>Pulmonary fibrosis (Option B):</strong> Seen more commonly in diffuse cutaneous systemic sclerosis (<strong>anti-Scl-70</strong> positive), not limited cutaneous disease.</p>\n<p><strong>Allergic Bronchopulmonary Aspergillosis (Option D):</strong> Complication of asthma or cystic fibrosis, unrelated to systemic sclerosis.</p>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary Eosinophilia</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Asthma</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic fibrosis</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital Tuberculosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A couple attend the GP with their 2-year-old daughter. She has a history of repeated chest infections, failure to thrive, and steatorrhoea (fatty stools). They also have an 8-year-old child who is fit and well. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1196109",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196109,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The combination of recurrent chest infections, malabsorption with steatorrhoea, and poor growth is highly suggestive of <strong>cystic fibrosis (CF).</strong></p>\n<ul>\n<li><strong>Cystic fibrosis</strong> is an autosomal recessive disorder caused by mutations in the <strong>CFTR gene</strong>, leading to defective chloride transport across epithelial cells.</li>\n<li>This results in thick, sticky secretions affecting multiple systems:\n<ul>\n<li><strong>Respiratory system</strong>: Recurrent chest infections (often Pseudomonas), bronchiectasis, chronic productive cough.</li>\n<li><strong>Gastrointestinal system</strong>: Pancreatic insufficiency causes malabsorption, steatorrhoea, and fat-soluble vitamin deficiencies.</li>\n<li><strong>Growth and development</strong>: Failure to thrive due to poor nutrient absorption.</li>\n<li><strong>Fertility</strong>: Male infertility due to congenital bilateral absence of the vas deferens.</li>\n</ul>\n</li>\n<li>The condition is inherited in an autosomal recessive manner, so the healthy sibling is likely a carrier or unaffected depending on inheritance.</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Pulmonary eosinophilia (Option A):</strong> Characterized by asthma-like symptoms and eosinophilia, not malabsorption or steatorrhoea.</p>\n<p><strong>Asthma (Option B):</strong> Causes wheeze and breathlessness but does not cause failure to thrive or fatty stools.</p>\n<p><strong>Congenital tuberculosis (Option D):</strong> Rare, presents with systemic illness (fever, lymphadenopathy, hepatosplenomegaly), not chronic malabsorption.</p>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">10</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">20</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">30</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">60</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In obstructive sleep Apnea, Apnea is defined as cessation of breathing for ______ seconds.</span></p>",
      "unique_key": "DT1196153",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196153,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>In <strong>OSA</strong>, apnea is defined as the cessation of airflow for at least <strong>10 seconds</strong> during sleep.</p>\n<ul>\n<li><strong>Obstructive sleep apnea</strong> is characterized by recurrent episodes of upper airway collapse during sleep, leading to apnea (no airflow) or hypopnea (reduction in airflow).</li>\n<li>The <strong>standard</strong> diagnostic definition requires:\n<ul>\n<li><strong>Apnea</strong>: Complete cessation of airflow at the nose and mouth for &ge;10 seconds, despite continued respiratory effort.</li>\n<li><strong>Hypopnea</strong>: Partial obstruction with &ge;30% reduction in airflow for &ge;10 seconds, associated with &ge;3-4% oxygen desaturation or arousal.</li>\n</ul>\n</li>\n<li>The <strong>severity</strong> is quantified by the <strong>Apnea-Hypopnea Index (AHI):</strong>\n<ul>\n<li>Mild: 5-15 events/hour</li>\n<li>Moderate: 15-30 events/hour</li>\n<li>Severe: &gt;30 events/hour</li>\n</ul>\n</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250915c8b17.png\">",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is required for the diagnosis of obesity hypoventilation syndrome?<br> 1. BMI > 25 kg/m2<br> 2. Sleep disorder breathing<br> 3. PaCO2 > 45 mm Hg<br> 4. Hypertension</span></p>",
      "unique_key": "DT1196160",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196160,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The diagnosis of <strong>OHS</strong> requires the presence of sleep-disordered breathing and daytime hypercapnia (PaCO<sub>2</sub> &gt; 45 mmHg).</p>\r\n<ul>\r\n<li><strong>Obesity hypoventilation syndrome</strong> is a disorder characterized by:\r\n<ul>\r\n<li>Obesity (traditionally BMI &ge;30 kg/m&sup2;; &ge;25 kg/m&sup2; is overweight, not always sufficient for OHS definition).</li>\r\n<li>Sleep-disordered breathing (usually obstructive sleep apnea but can also be non-obstructive sleep-related hypoventilation).</li>\r\n<li>Daytime hypercapnia with PaCO<sub>2</sub> &gt; 45 mmHg.</li>\r\n</ul>\r\n</li>\r\n<li>Hypertension is often a comorbidity but not required for diagnosis.</li>\r\n<li>Similarly, while most patients with OHS are obese (BMI &ge;30), BMI &gt;25 alone does not establish OHS unless hypercapnia and sleep-disordered breathing are also present.</li>\r\n</ul>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Uvulopharyngoplasty</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Continuous positive alveolar pressure (CPAP) machine overnight</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Bi-level positive alveolar pressure (BiPAP) overnight</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Mandibular advancement device</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 46-year-old female with morbid obesity is brought to the physician by her husband for complaints of excessive snoring at night. On further questioning, she reports having daytime sleepiness occasionally. A polysomnography is done, which shows 6 episodes of apnoea per hour of sleep. What is the best modality to treat this patient?</span></p>",
      "unique_key": "DT1196170",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196170,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>CPAP</strong> is the <strong>gold standard</strong> treatment for obstructive sleep apnea (OSA), as it prevents airway collapse during sleep.</p>\n<ul>\n<li>This patient has obstructive sleep apnea (OSA), as indicated by excessive snoring, daytime sleepiness, obesity, and polysomnography showing apneic episodes (apnea-hypopnea index &gt;5).</li>\n<li>CPAP delivers constant positive pressure throughout the respiratory cycle, keeping the pharyngeal airway open, thereby preventing repetitive collapse, snoring, and apnea events.</li>\n<li>It improves sleep quality, reduces daytime somnolence, and prevents long-term cardiovascular complications (HTN, arrhythmias, stroke).</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Uvulopharyngoplasty (Option A):</strong> A surgical procedure that removes redundant tissue from the oropharynx; reserved for refractory cases, not first-line.</p>\n<p><strong>BiPAP (Option C):</strong> Provides different pressures for inspiration and expiration; used in obesity hypoventilation syndrome or hypercapnic respiratory failure, not first-line for uncomplicated OSA.</p>\n<p><strong>Mandibular advancement device (Option D):</strong> Helpful in mild OSA or patients intolerant to CPAP, but not the best choice in moderate/severe OSA.</p>\n<p><strong>Management of OSA:</strong></p>\n<ul>\n<li>Weight loss</li>\n<li>CPAP: standard medical therapy with the highest level of evidence for efficacy. Delivered through a nasal or nasal-oral mask, CPAP works as a mechanical splint to hold the airway open, thus maintaining airway patency during sleep.</li>\n<li>Mandibular advancement devices: used for treating patients with mild/moderate OSA or patients who do not tolerate CPAP</li>\n<li>Uvulopalatopharyngoplasty: less successful than treatment with oral appliances; reserved for the treatment of patients who snore, have mild OSA, or cannot tolerate CPAP</li>\n<li>Upper airway neurostimulation: Unilateral stimulation of the hypoglossal nerve through a surgically implanted device; reserved for patients who cannot tolerate or fail CPAP therapy. with moderate to severe OSA</li>\n</ul>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">pulmonary embolism</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancreatitis</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Tuberculosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are causes of haemorrhagic pleural effusion except:</span></p>",
      "unique_key": "DT1196176",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196176,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>Hemorrhagic pleural effusion refers to pleural fluid with significant blood admixture, commonly seen in conditions that damage pleural vessels or cause bleeding into the pleural space.</p>\n<ul>\n<li>Common causes include pulmonary embolism, tuberculosis, trauma, pancreatitis, and malignancy.</li>\n<li>Rheumatoid arthritis, however, causes a chronic exudative effusion that is typically sterile, with low glucose and low complement, but not hemorrhagic.</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Pulmonary embolism (Option A):</strong> Can cause hemorrhagic effusion due to infarction of lung parenchyma.</p>\n<p><strong>Pancreatitis (Option C):</strong> Causes hemorrhagic effusion due to pancreatic enzyme leakage causing pleural irritation and bleeding.</p>\n<p><strong>Tuberculosis (Option D):</strong> A common cause of hemorrhagic exudative effusion due to pleural inflammation and vessel involvement.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509153e0d8.png\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250915b6b80.png\">",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased PaO2</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased PaCO2</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal PaCO2</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal A-a gradient</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are causes of haemorrhagic pleural effusion except:</span></p>",
      "unique_key": "DT1196182",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196182,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>A <strong>normal alveolar&ndash;arterial (A-a) gradient</strong> indicates hypoxemia is due to hypoventilation or high altitude, not lung disease.</p>\r\n<ul>\r\n<li><strong>Hypoxemia</strong> can be caused by five mechanisms:\r\n<ul>\r\n<li>Low inspired O<sub>2</sub> (high altitude)</li>\r\n<li>Hypoventilation</li>\r\n<li>V/Q mismatch</li>\r\n<li>Diffusion impairment</li>\r\n<li>Right-to-left shunt</li>\r\n</ul>\r\n</li>\r\n<li>In pulmonary causes (V/Q mismatch, diffusion defect, shunt), the A-a gradient is increased because alveolar oxygen is normal, but arterial oxygen drops.</li>\r\n<li>If the A-a gradient is normal, it suggests hypoxemia is due to hypoventilation (e.g., CNS depression, neuromuscular weakness, obesity hypoventilation) or low FiO<sub>2</sub> (high altitude), not intrinsic lung disease.</li>\r\n</ul>",
      "correct_choice_id": 164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural fluid protein</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural fluid LDH</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum protein</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural fluid glucose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following parameters is not useful in analysing Light's criteria for pleural effusion?</span></p>",
      "unique_key": "DT1196202",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196202,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Light's criteria </strong>use pleural fluid protein, serum protein, and pleural fluid LDH (with serum LDH) - but not pleural fluid glucose.</p>\n<ul>\n<li><strong>Light's criteria </strong>are the most widely used method to differentiate exudative from transudative pleural effusions.</li>\n<li>According to Light's criteria, an effusion is exudative if any one of the following is true:\n<ul>\n<li><strong>Pleural fluid protein / Serum protein ratio &gt; 0.5</strong></li>\n<li><strong>Pleural fluid LDH / Serum LDH ratio &gt; 0.6</strong></li>\n<li><strong>Pleural fluid LDH &gt; two-thirds the upper limit of normal serum LDH</strong></li>\n</ul>\n</li>\n<li><strong>Pleural fluid glucose is not part of Light's criteria.</strong></li>\n<li>However, pleural fluid glucose is clinically useful in identifying conditions like rheumatoid pleuritis, empyema, TB, and malignancy, where glucose is often low.</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Pleural fluid protein (Option A): </strong>Part of Light's criteria (used in PF/S protein ratio).</p>\n<p><strong>Pleural fluid LDH (Option B): </strong>Essential part of Light's criteria (absolute value and ratio with serum LDH).</p>\n<p><strong>Serum protein (Option C): </strong>Required to calculate PF/S protein ratio.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250915d08c3.png\">",
      "correct_choice_id": 174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Moderate</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Mild</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Very severe</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old male chronic smoker was recently diagnosed to have chronic obstructive pulmonary disease. He has a FEV1 of 40% predicted. What is his severity of the disease according to the GOLD classification?</span></p>",
      "unique_key": "DT1196207",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196207,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This patient is in GOLD stage 3 (FEV1 30-49% predicted), which is considered severe COPD.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250915bb915.png\">",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyper inflated lung fields</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Pursed lip breathing</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Clubbing</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Polycythaemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following goes against a diagnosis of chronic obstructive pulmonary disease?</span></p>",
      "unique_key": "DT1196210",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196210,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Clubbing</strong> is not a feature of COPD; its presence should raise the suspicion of an underlying lung malignancy.</p>\n<p><strong>Findings of COPD:</strong></p>\n<ul>\n<li>Nicotine staining of fingernails</li>\n<li>Signs of respiratory distress: pursed lip breathing, accessory muscle use, tripod position, inspiratory drawing of ribs (esp lower ribs, ka Hoover's sign) <strong>(Option B ruled out)</strong></li>\n<li>Cachexia (poor prognostic finding)</li>\n<li>Signs of hyperinflated lungs: barrel chest, hyper-resonance on percussion <strong>(Option A ruled out)</strong></li>\n<li>Auscultation: coarse crepitations (fibrosis), polyphonic rhonchi</li>\n<li>Signs of right heart failure (cor pulmonale): Elevated JVP, Pedal oedema, and ascites.</li>\n<li>Labs may show a 2&deg; polycythaemia and chronic respiratory acidosis with metabolic alkalosis. <strong>(Option D ruled out)</strong></li>\n</ul>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Low symptoms, high risk</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Low symptoms, low risk</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">High symptoms, low risk</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">High symptoms, high risk</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old female, diagnosed with COPD 2 years ago, has had 1 exacerbation in the past 1 year, which did not require hospitalisation. On assessing her symptoms, she reported getting breathless after walking a few minutes on level ground. What is her category of severity as per the current GOLD classification?</span></p>",
      "unique_key": "DT1196214",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196214,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>She has <strong>high symptoms</strong> (mMRC &ge;2) but <strong>low risk</strong> (1 mild exacerbation, no hospitalisation), placing her in GOLD category B / high symptoms, low risk.</p>\n<ul>\n<li>The <strong>GOLD 2023 classification</strong> for COPD severity uses two axes:</li>\n<li><strong>Symptoms</strong>:\n<ul>\n<li>Assessed by mMRC dyspnoea scale or COPD Assessment Test (CAT).</li>\n<li>mMRC &ge;2 &rarr; high symptoms; &lt;2 &rarr; low symptoms.</li>\n<li>This patient is breathless after walking a few minutes (mMRC 2&ndash;3), so high symptoms.</li>\n</ul>\n</li>\n<li><strong>Risk of exacerbations</strong>:\n<ul>\n<li>High risk: &ge;2 exacerbations per year or &ge;1 hospitalisation for exacerbation.</li>\n<li>Low risk: &le;1 exacerbation per year without hospitalisation.</li>\n<li>This patient had 1 mild exacerbation, no hospitalisation &rarr; low risk.</li>\n</ul>\n</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250915df268.png\">\n<p><strong>mMRC grading:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250915a3bdb.png\">",
      "correct_choice_id": 203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Resting O<sub>2</sub> saturation < 90%</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Resting O<sub>2</sub> saturation < 95%</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Resting O<sub>2</sub> saturation &le;89% with signs of pulmonary arterial hypertension</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is/are an indication for long-term oxygen therapy for patients with COPD?</span></p>",
      "unique_key": "DT1196219",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196219,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\r\n<p><strong>LTOT</strong> is indicated in COPD patients with severe hypoxemia (PaO<sub>2</sub> &le;55 mmHg or SpO<sub>2</sub> &le;88%) or moderate hypoxemia (PaO<sub>2</sub> 56-59 mmHg / SpO<sub>2</sub> &le;89%) with evidence of right heart strain, polycythemia, or pulmonary hypertension.</p>\r\n<ul>\r\n<li><strong>Long-term oxygen therapy</strong> improves survival, exercise tolerance, and quality of life in COPD patients with significant hypoxemia.</li>\r\n<li>Indications are based on oxygen saturation / PaO<sub>2</sub> and presence of complications:\r\n<ul>\r\n<li>Severe hypoxemia:\r\n<ul>\r\n<li>PaO<sub>2</sub> &le;55 mmHg or SpO<sub>2</sub> &le;88% at rest &rarr; LTOT indicated.</li>\r\n</ul>\r\n</li>\r\n<li>Moderate hypoxemia with complications:\r\n<ul>\r\n<li>PaO<sub>2</sub> 56-59 mmHg or SpO<sub>2</sub> &le;89% plus one of the following:\r\n<ul>\r\n<li>Pulmonary hypertension</li>\r\n<li>Right heart failure / cor pulmonale</li>\r\n<li>Secondary polycythemia (Hct &gt;55%)</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>Not indicated:\r\n<ul>\r\n<li>SpO<sub>2</sub> &gt;90-92% at rest without complications.</li>\r\n<li>Temporary desaturation on exertion only (ambulatory oxygen may be considered).</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>Application to the patient:\r\n<ul>\r\n<li>Option C specifies SpO<sub>2</sub> &le;89% with signs of pulmonary arterial hypertension, which is an established indication for LTOT.</li>\r\n</ul>\r\n</li>\r\n</ul>",
      "correct_choice_id": 213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Sputum cytology</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">CT scan of the lung</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Transbronchial biopsy</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old male presents with a history of hemoptysis and is admitted to the hospital. He has been a heavy smoker for 25 years. A chest X-ray shows a mass in the right upper lobe. Which is the best test to investigate at present?</span></p>",
      "unique_key": "DT1196278",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196278,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>A <strong>contrast-enhanced CT scan</strong> is the preferred next step for characterising a lung mass, assessing local extent, mediastinal involvement, and lymphadenopathy, before planning biopsy.</p>\n<ul>\n<li>Initial evaluation of a suspected lung mass begins with imaging to define size, location, and involvement of adjacent structures.</li>\n<li><strong>CT chest</strong> (contrast-enhanced) provides:\n<ul>\n<li>Precise localisation of the lesion</li>\n<li>Involvement of mediastinum, vessels, or chest wall</li>\n<li>Guidance for subsequent biopsy (bronchoscopic, percutaneous, or surgical)</li>\n</ul>\n</li>\n<li>Sputum cytology is less sensitive (~50% for central tumors, lower for peripheral lesions) and cannot replace imaging.</li>\n<li>Transbronchial biopsy is invasive and usually performed after CT localisation to target the lesion.</li>\n<li>Pleural biopsy is indicated only if there is pleural effusion suggestive of malignancy, which is not mentioned here.</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Sputum cytology (Option A):</strong> Low sensitivity, cannot fully characterise the lesion or staging.</p>\n<p><strong>Transbronchial biopsy (Option C):</strong> Needs prior imaging for safe and accurate targeting.</p>\n<p><strong>Pleural biopsy (Option D):</strong> Only indicated if pleural involvement or effusion is present.</p>",
      "correct_choice_id": 222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">FEV1 of 1.7 L (50% predicted)</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Horner's syndrome</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">History of myocardial infarction</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypercalcaemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old man has a diagnosis of non-small cell lung tumour, and has completed a set of investigations. Which one of the following is a contraindication to lung surgery?</span></p>",
      "unique_key": "DT1196291",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196291,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Horner's syndrome</strong> in a patient with NSCLC indicates a Pancoast tumour with invasion of the brachial plexus or sympathetic chain, which makes surgical resection typically unfeasible.</p>\r\n<ul>\r\n<li>Surgical resection in NSCLC is contraindicated when there is tumour invasion of critical structures:\r\n<ul>\r\n<li>Vertebral bodies</li>\r\n<li>Brachial plexus above T1</li>\r\n<li>Subclavian vessels</li>\r\n<li>Mediastinal structures</li>\r\n</ul>\r\n</li>\r\n<li>Horner's syndrome (ptosis, miosis, anhidrosis) arises from tumour invasion of the sympathetic chain, typically seen in superior sulcus / Pancoast tumours.</li>\r\n<li>This indicates local unresectability in many cases.</li>\r\n<li>Other contraindications to surgery include diffuse metastatic disease, involvement of both lungs, or poor cardiopulmonary reserve, but these are not absolute in this patient.</li>\r\n</ul>\r\n<p><strong>Explanation of incorrect options</strong></p>\r\n<p><strong>FEV<sub>1</sub> of 1.7 L (50% predicted) (Option A):</strong> Acceptable pulmonary function for lobectomy; may require careful preoperative assessment.</p>\r\n<p><strong>History of myocardial infarction (Option C):</strong> Not an absolute contraindication; perioperative cardiac risk assessment is needed.</p>\r\n<p><strong>Hypercalcaemia (Option D):</strong> May need correction, but not an absolute contraindication for surgery.</p>\r\n<p><strong>Left-sided Horner's syndrome:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509157b080.png\">",
      "correct_choice_id": 232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Mesothelioma</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Small cell lung carcinoma</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell lung carcinoma</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma of the lung</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 68-year-old man with weight loss has a chest x-ray that shows a cavitating lung lesion. Out of the following causes, which is most likely to cause a cavitating lung lesion?</span></p>",
      "unique_key": "DT1196296",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196296,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Squamous cell carcinoma of the lung</strong> frequently presents as a cavitating lesion on imaging due to central necrosis.</p>\n<ul>\n<li><strong>Squamous cell lung carcinoma</strong> (SCC) is typically:\n<ul>\n<li>Centrally located near the main bronchi</li>\n<li>Prone to cavitation due to central tumour necrosis</li>\n<li>Strongly associated with smoking</li>\n</ul>\n</li>\n<li>Cavitation is less commonly seen with:\n<ul>\n<li>Adenocarcinoma: usually peripheral, solid, non-cavitating</li>\n<li>Small cell carcinoma: central, rarely cavitates</li>\n<li>Mesothelioma: pleural-based, does not cavitate</li>\n</ul>\n</li>\n<li>On CXR or CT, a thick-walled cavity in the central lung, especially in a smoker, is most suggestive of squamous cell carcinoma.</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Mesothelioma (Option A):</strong> Primarily pleural-based, does not form lung parenchymal cavities.</p>\n<p><strong>Small cell lung carcinoma (Option B):</strong> Central, rapidly growing, but cavitation is rare.</p>\n<p><strong>Adenocarcinoma of the lung (Option D):</strong> Usually peripheral, solid, rarely cavitating.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509154b617.png\">\n<p><strong>A cavitating carcinomatous lung lesion</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250915374ea.png\">",
      "correct_choice_id": 243,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Wegener's granulomatosis</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Good pasture's syndrome</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Carcinoid tumour</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Sarcoidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old male presents with a 6-month history of intermittent haemoptysis. He describes episodes of cutaneous flushing, which typically affect the head and neck. The episodes are often associated with an unpleasant warm feeling, an itching feeling. They last for half an hour. He is slightly breathless but has had no evidence of leg swelling or chest pain. He smokes 10 cigarettes a day. He has lost 3 kg of weight in the past two months and has been experiencing night sweats. A Chest x-ray shows a sail sign in the left lower lobe, but no visible consolidation. Which one of the following is the most likely diagnosis?</span></p>",
      "unique_key": "DT1196301",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196301,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p><strong>Carcinoid tumours</strong> are neuroendocrine tumours that can produce flushing and pruritus (carcinoid syndrome) and may cause haemoptysis due to endobronchial involvement.</p>\n<ul>\n<li>Carcinoid tumour <strong>features</strong>:\n<ul>\n<li>Usually centrally located in the bronchi, can cause haemoptysis.</li>\n<li>Secretes serotonin and other vasoactive substances, causing episodic flushing, warmth, and pruritus.</li>\n<li>May cause weight loss and subtle constitutional symptoms.</li>\n<li>Chest X-ray may show endobronchial lesion or subtle signs (like a sail sign if the lung is partially collapsed due to obstruction).</li>\n</ul>\n</li>\n<li>Other causes of haemoptysis (e.g., infection, autoimmune) usually do not produce flushing.</li>\n<li>Carcinoid syndrome is less common in lung carcinoids than in gastrointestinal carcinoids but can occur.</li>\n</ul>\n<p><strong>Explanation of incorrect options</strong></p>\n<p><strong>Wegener's granulomatosis (Option A):</strong> Can cause haemoptysis, but does not cause episodic flushing; associated with sinusitis and renal involvement.</p>\n<p><strong>Goodpasture's syndrome (Option B):</strong> Causes haemoptysis and renal failure, but no flushing or pruritus.</p>\n<p><strong>Sarcoidosis (Option D):</strong> Usually asymptomatic or causes cough and dyspnoea; flushing is not a feature.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509155db80.png\">\n<p><strong>Sail sign (straight line around the heart border)</strong></p>",
      "correct_choice_id": 253,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchoscopy</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung function tests</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Spiral CT of the chest</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Thoracoscopy and biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old man has had 5 kg weight loss over 6 months. He is an ex-smoker of 25 cigarettes a day for 40 years and used to work in a coal mine. A Chest X-ray shows a large right-sided pleural effusion and several pleural plaques in both lung peripheries. Pleural aspiration reveals an exudate with 42 g of protein. What investigation should be recommended?</span></p>",
      "unique_key": "DT1196305",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196305,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Thoracoscopy</strong> with pleural biopsy is the <strong>gold standard</strong> for diagnosing malignant pleural disease, especially in patients with pleural effusion and asbestos-related pleural plaques.</p>\n<ul>\n<li><strong>Clinical reasoning</strong>:\n<ul>\n<li>Red flags: Weight loss, exudative pleural effusion, and pleural plaques raise suspicion for malignant mesothelioma.</li>\n<li>Occupational exposure: Coal mining and asbestos exposure are strong risk factors for pleural malignancy.</li>\n</ul>\n</li>\n<li>Pleural fluid analysis:\n<ul>\n<li>Protein &gt;30 g/L confirms an exudative effusion (Light's criteria).</li>\n<li>Cytology alone has limited sensitivity (~30-40%) for mesothelioma.</li>\n</ul>\n</li>\n<li><strong>Thoracoscopy</strong>:\n<ul>\n<li>Allows direct visualisation of the pleura and targeted biopsy.</li>\n<li>Sensitivity for detecting mesothelioma approaches 95-98%, much higher than cytology or imaging.</li>\n</ul>\n</li>\n<li>Other investigations:\n<ul>\n<li><strong>Bronchoscopy (Option A ruled out):</strong> Useful for endobronchial lesions but not primary pleural malignancy.</li>\n<li><strong>Lung function tests (Option B ruled out):</strong> Assess baseline function, not diagnostic.</li>\n<li><strong>Spiral CT (Option C ruled out):</strong> Provides imaging detail but cannot provide tissue diagnosis.</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 264,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Disseminated intravascular coagulation</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertrophic pulmonary osteoarthropathy (HPOA)</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Thrombocytosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old man with a smoking history of 50 cigarettes per day for many years has had a chest radiograph showing a lung mass. He is presently waiting for a bronchoscopy. Which one of the following supports a diagnosis of small cell lung cancer?</span></p>",
      "unique_key": "DT1196309",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196309,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>SIADH</strong> is a <strong>classic paraneoplastic syndrome</strong> associated with small cell lung cancer due to ectopic ADH secretion.</p>\n<ul>\n<li><strong>Small cell lung cancer</strong> (SCLC):\n<ul>\n<li>Neuroendocrine tumour strongly associated with smoking.</li>\n<li>Commonly centrally located, often detected as a lung mass.</li>\n<li>Frequently causes paraneoplastic syndromes, the most classic being:\n<ul>\n<li>SIADH &rarr; leads to hyponatremia</li>\n<li>Cushing's syndrome (ACTH secretion)</li>\n<li>Lambert-Eaton myasthenic syndrome</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>SIADH features</strong>:\n<ul>\n<li>Hyponatremia with low plasma osmolality</li>\n<li>High urine sodium and osmolality</li>\n<li>Patients may present with lethargy, confusion, seizures in severe cases</li>\n</ul>\n</li>\n<li>Other associations:\n<ul>\n<li><strong>DIC (Option A ruled out):</strong> More commonly associated with adenocarcinoma or metastatic cancer, not classic for SCLC.</li>\n<li><strong>Hypertrophic pulmonary osteoarthropathy (HPOA) (Option B ruled out):</strong> Typically seen with non-small cell lung cancers, particularly adenocarcinoma.</li>\n<li><strong>Thrombocytosis (Option D ruled out):</strong> Can occur in many solid tumors but not specific for SCLC.</li>\n</ul>\n</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509151bbe3.png\">",
      "correct_choice_id": 273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}